Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Expert calls for new approach to equine laminitis
Professor McGowan highlighted three major advances in the understanding of laminitis.

Study findings pave the way for new research and treatment

An equine specialist is calling for a new approach to equine laminitis as recent research shows most cases of laminitis are a clinical sign of systemic disease.

Writing in The Veterinary Journal, Professor Cathy McGowan from the University of Liverpool said that her findings ‘have provoked a rethink of our clinical and research strategies for this condition’.

For the past decade, Professor McGowan has been leading an investigation into laminitis caused by hormonal dysregulation and endocrine laminitis. Her ground-breaking work revealed that laminitis was caused by insulin - overturning previous ideas about the disease and paving the way for new research and treatment.

Professor McGowan gained an understanding of abnormal insulin regulation from her work as a veterinary specialist where she has treated many horses and ponies with endocrine diseases. She noted that what they all had in common was abnormal insulin regulation.

In her research, Professor McGowan highlighted three major advances in the understanding of laminitis: First, laminitis is now considered to be a disease that affects multiple organs and tissues, or affects the body systemically. Second, endocrine laminitis is now believed to be the predominant form in animals presenting for lameness.

Her third discovery was that, under the microscope, changes in the hoof lamellae were subtle in comparison with previous descriptions. She noted that some horses may experience a prolonged subclinical phase, as demonstrated by the development of divergent hoof rings visible on the hoof wall.

“These findings completely change the way we think about a very important disease in horses,” Professor McGowan explained. “This is very important to the equine industry and veterinary profession and will be the basis of future research directions.”

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'